DFNA5 Polyclonal Antibody, 100ul Drug Development and Evaluation a disorder characterized by severely
Pay in 4 interest-free payments of $35.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Live Spec
DFNA5 Polyclonal Antibody, 100ul Drug Development and Evaluation a disorder characterized by severelyHearing impairment is a heterogeneous condition with over 40 loci described. Non syndromic hearing impairment protein 5 encoded by DFNA5 is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene.
Store: livefragrantly.com · Domain: livefragrantly.com
























